Speakers

Lucy Clossick Thomson


Director Clinical Operations Strategy - AstraZeneca





Lucy Clossick Thomson

Sessions


  • Thursday - April 26, 2018 - 14:00

    Implementing risk proportionate approaches in clinical trials -moving towards risk based monitoring

    • Choosing a risk based approach appropriate for Revision 2
    • Adopting a strategy proportionate to the risks identified within a study
    • Risk-based monitoring needs to be appropriate to the phase of trial and take account of the site experience to assess, manage and mitigate risk


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now